A novel variant in the <em>MAP3K1</em> genomic locus reveals abnormal cell apoptosis as a potential pathogenic mechanism in 46, XY disorders of sex development

Lu,Yufu; Wei,Sijia; Wang,Shuang; Zhang,Jingzhi; Xu,Yongjie; Huang,Changyudong; Pan,Wei; Wang,Zhengrong

doi:10.3892/mmr.2025.13589

A novel variant in the MAP3K1 genomic locus reveals abnormal cell apoptosis as a potential pathogenic mechanism in 46, XY disorders of sex development

Authors:
- Yufu Lu
- Sijia Wei
- Shuang Wang
- Jingzhi Zhang
- Yongjie Xu
- Changyudong Huang
- Wei Pan
- Zhengrong Wang
View Affiliations

Affiliations: Guizhou Prenatal Diagnosis Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China
Published online on: June 5, 2025 https://doi.org/10.3892/mmr.2025.13589
Article Number: 224
Copyright: © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Disorders of sex development (DSDs) are characterized by discrepancies among karyotype, the gonadal phenotype and gonadal anatomy following birth. Among these, 46, XY DSD is the most complex sub‑type and a major cause of birth defects associated with sexual development. However, due to the considerable heterogeneity in pathogenic genes, numerous cases remain genetically undiagnosed. In the present study, a novel gain‑of‑function variant was identified in the mitogen‑activated protein 3 kinase 1 (MAP3K1) gene, contributing to 46, XY DSD through the induction of abnormal cell apoptosis. Genetic analysis of a pediatric male patient and his family revealed a heterozygous MAP3K1 c.4445 G>A variant, resulting in an arginine‑to‑glutamine substitution. The variant site is highly conserved across species and the amino acid transition induced structural changes in the MAP3K1 protein. In vitro experiments demonstrated that the MAP3K1 c.4445 G>A variant markedly increased apoptotic signaling, leading to abnormal cell apoptosis, disruption of the cell cycle and reduced cell viability. Moreover, the variant exhibited increased levels of ERK1/2 and p38 phosphorylation, indicative of a gain‑of‑function effect. Subsequent analysis revealed increased expression of the testis‑determining gene, SOX9 and reduced expression of the ovary‑determining gene, FOXL2. Notably, alterations in gene expression were associated with the MAP3K1 c.4445 G>A variant, providing a mechanistic basis for the pathogenesis of 46, XY DSD. Collectively, these findings offer novel insights into the anti‑apoptotic role of MAP3K1, advancing genetic diagnosis and pre‑natal screening for individuals with DSDs.

View Figures

View References

1	Lucas-Herald AK, Ali SR, McMillan C, Rodie ME, McMillan M, Bryce J and Ahmed SF: I-DSD: The first 10 years. Horm Res Paediatr. 96:238–246. 2023. View Article : Google Scholar : PubMed/NCBI
2	Grinspon RP, Bergadá I and Rey RA: Male Hypogonadism and disorders of sex development. Front Endocrinol (Lausanne). 11:2112020. View Article : Google Scholar : PubMed/NCBI
3	Hughes IA, Houk C, Ahmed SF and Lee PA; Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology Consensus Group, : Consensus statement on management of intersex disorders. J Pediatr Urol. 2:148–162. 2006. View Article : Google Scholar : PubMed/NCBI
4	Jiali C, Huifang P, Yuqing J, Xiantao Z and Hongwei J: Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: Geographic and ethnic differences in variants. Front Genet. 15:13875982024. View Article : Google Scholar : PubMed/NCBI
5	Xue M, Wang X, Li C, Zhao M, He F and Li X: Novel pathogenic mutations in disorders of sex development associated genes cause 46,XY complete gonadal dysgenesis. Gene. 718:1440722019. View Article : Google Scholar : PubMed/NCBI
6	Reyes AP, León NY, Frost ER and Harley VR: Genetic control of typical and atypical sex development. Nat Rev Urol. 20:434–451. 2023. View Article : Google Scholar : PubMed/NCBI
7	Granados A, Alaniz VI, Mohnach L, Barseghyan H, Vilain E, Ostrer H, Quint EH, Chen M and Keegan CE: MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature. Am J Med Genet C Semin Med Genet. 175:253–259. 2017. View Article : Google Scholar : PubMed/NCBI
8	Loke J, Pearlman A, Radi O, Zuffardi O, Giussani U, Pallotta R, Camerino G and Ostrer H: Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. Hum Mol Genet. 23:1073–1083. 2014. View Article : Google Scholar : PubMed/NCBI
9	Stewart MK, Bernard P, Ang CS, Mattiske DM and Pask AJ: Oestrogen activates the MAP3K1 cascade and β-catenin to promote granulosa-like cell fate in a human testis-derived cell line. Int J Mol Sci. 22:100462021. View Article : Google Scholar : PubMed/NCBI
10	Pearlman A, Loke J, Le Caignec C, White S, Chin L, Friedman A, Warr N, Willan J, Brauer D, Farmer C, et al: Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet. 87:898–904. 2010. View Article : Google Scholar : PubMed/NCBI
11	Cheng Y, Xu C, Yang J, Zhou X and Chen N: Identification of a novel MAP3K1 variant in a family with 46, XY DSD and partial growth hormone deficiency. Mol Med Rep. 26:3382022. View Article : Google Scholar : PubMed/NCBI
12	Yujiri T, Fanger GR, Garrington TP, Schlesinger TK, Gibson S and Johnson GL: MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton. J Biol Chem. 274:12605–12610. 1999. View Article : Google Scholar : PubMed/NCBI
13	Yujiri T, Sather S, Fanger GR and Johnson GL: Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1911–1914. 1998. View Article : Google Scholar : PubMed/NCBI
14	Minamino T, Yujiri T, Papst PJ, Chan ED, Johnson GL and Terada N: MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc Natl Acad Sci USA. 96:15127–15132. 1999. View Article : Google Scholar : PubMed/NCBI
15	Krivega M, Zimmer J, Slezko A, Frank-Herrmann P, Rehnitz J, Hohenfellner M, Bettendorf M, Luzarowski M and Strowitzki T: Genomic instability in individuals with sex determination defects and germ cell cancer. Cell Death Discov. 9:1732023. View Article : Google Scholar : PubMed/NCBI
16	Alfano M, Tascini AS, Pederzoli F, Locatelli I, Nebuloni M, Giannese F, Garcia-Manteiga JM, Tonon G, Amodio G, Gregori S, et al: Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia. Nat Commun. 12:52052021. View Article : Google Scholar : PubMed/NCBI
17	Bailly A and Gartner A: Germ cell apoptosis and DNA damage responses. Adv Exp Med Biol. 757:249–276. 2013. View Article : Google Scholar : PubMed/NCBI
18	Wang LF, Wang KY, Tu HJ, Lin K and Lin H: Clinical investigation of chromosome karyotype analysis with amniotic fluids cell and parental peripheral blood. Clin Lab. 68:2022. View Article : Google Scholar
19	Yi T, Sun H, Fu Y, Hao X, Sun L, Zhang Y, Han J, Gu X, Liu X, Guo Y, et al: Genetic and clinical features of heterotaxy in a prenatal cohort. Front Genet. 13:8182412022. View Article : Google Scholar : PubMed/NCBI
20	Castro S, Brunello FG, Sansó G, Izquierdo A, Zaiat J, Urrutia M, Martí M, Rey RA, Tellechea ML and Grinspon RP: Clinical presentation of congenital hypogonadotropic hypogonadism in males with delayed puberty according to genetic etiology: A systematic review and meta-analysis after reclassification of gene variants. Hum Reprod. 40:904–918. 2025. View Article : Google Scholar : PubMed/NCBI
21	Cheng Y, Chen J, Zhou X, Yang J, Ji Y and Xu C: Characteristics and possible mechanisms of 46, XY differences in sex development caused by novel compound variants in NR5A1 and MAP3K1. Orphanet J Rare Dis. 16:2682021. View Article : Google Scholar : PubMed/NCBI
22	Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF and Yu T: CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther. 8:362023. View Article : Google Scholar : PubMed/NCBI
23	Liao S, Wu J, Liu R, Wang S, Luo J, Yang Y, Qin Y, Li T, Zheng X, Song J, et al: A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: Role of Akt(Ser473)/GSK3β (Ser9)-mediated Nrf2 activation. Redox Biol. 36:1016442020. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Ostrer H: Pathogenic variants in MAP3K1 cause 46,XY gonadal dysgenesis: A review. Sex Dev. 16:92–97. 2022. View Article : Google Scholar : PubMed/NCBI
26	Elzaiat M, McElreavey K and Bashamboo A: Genetics of 46,XY gonadal dysgenesis. Best Pract Res Clin Endocrinol Metab. 36:1016332022. View Article : Google Scholar : PubMed/NCBI
27	Chamberlin A, Huether R, Machado AZ, Groden M, Liu HM, Upadhyay K, O V, Gomes NL, Lerario AM, Nishi MY, et al: Mutations in MAP3K1 that cause 46,XY disorders of sex development disrupt distinct structural domains in the protein. Hum Mol Genet. 28:1620–1628. 2019. View Article : Google Scholar : PubMed/NCBI
28	Qian C, Wu Z, Ng RC, Garcia-Barceló MM, Yuan ZW, Wong KKY, Tam PKH and Lui VCH: Conditional deletion of platelet derived growth factor receptor alpha (Pdgfra) in urorectal mesenchyme causes mesenchyme apoptosis and urorectal developmental anomalies in mice. Cell Death Differ. 26:1396–1410. 2019. View Article : Google Scholar : PubMed/NCBI
29	Yamada G, Satoh Y, Baskin LS and Cunha GR: Cellular and molecular mechanisms of development of the external genitalia. Differentiation. 71:445–460. 2003. View Article : Google Scholar : PubMed/NCBI
30	Glenister TW: The origin and fate of the urethral plate in man. J Anat. 88:413–425. 1954.PubMed/NCBI
31	Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga LH III, et al: Global disorders of sex development update since 2006: Perceptions, approach and care. Horm Res Paediatr. 85:158–180. 2016. View Article : Google Scholar : PubMed/NCBI
32	Rosenfield RL: Normal and premature adrenarche. Endocr Rev. 42:783–814. 2021. View Article : Google Scholar : PubMed/NCBI
33	Arya S, Kumar S, Lila AR, Sarathi V, Memon SS, Barnabas R, Thakkar H, Patil VA, Shah NS and Bandgar TR: Exonic WT1 pathogenic variants in 46,XY DSD associated with gonadoblastoma. Endocr Connect. 10:1522–1530. 2021. View Article : Google Scholar : PubMed/NCBI
34	Dehghan N, Mousavikia SN, Qasempour Y and Azimian H: Radiation-induced senescence in glioblastoma: An overview of the mechanisms and eradication strategies. Life Sci. 359:1232182024. View Article : Google Scholar : PubMed/NCBI